BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36014764)

  • 1. Appraising the Causal Association between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study.
    Wang X; Wang X; Gong Y; Chen X; Zhong D; Zhu J; Zhuang L; Gao J; Fu G; Lu X; Lai D
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization study reveals a causal relationship between serum iron status and coronary heart disease and related cardiovascular diseases.
    Liu F; Liu Y; Xu S; Wang Q; Xu F; Liu Y
    Front Cardiovasc Med; 2023; 10():1152201. PubMed ID: 37383700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
    Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
    PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal relationships between the gut microbiome, blood lipids, and heart failure: a Mendelian randomization analysis.
    Dai H; Hou T; Wang Q; Hou Y; Wang T; Zheng J; Lin H; Zhao Z; Li M; Wang S; Zhang D; Dai M; Zheng R; Lu J; Xu Y; Chen Y; Ning G; Wang W; Bi Y; Xu M
    Eur J Prev Cardiol; 2023 Sep; 30(12):1274-1282. PubMed ID: 37195998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.
    Wang H; Guo Z; Zheng Y; Chen B
    BMC Cardiovasc Disord; 2022 Jun; 22(1):262. PubMed ID: 35690714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Status and Risk of Heart Disease, Stroke, and Diabetes: A Mendelian Randomization Study in European Adults.
    Liu Y; Clarke R; Bennett DA; Zong G; Gan W
    J Am Heart Assoc; 2024 Mar; 13(6):e031732. PubMed ID: 38497484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically Predicted Serum Iron Status Is Associated with Altered Risk of Systemic Lupus Erythematosus among European Populations.
    Ye D; Zhu Z; Huang H; Sun X; Liu B; Xu X; He Z; Li S; Wen C; Mao Y
    J Nutr; 2021 Jun; 151(6):1473-1478. PubMed ID: 33693920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraising the Associations Between Systemic Iron Status and Epigenetic Clocks: A Genetic Correlation and Bidirectional Mendelian Randomization Study.
    Guo Y; Li D; Hu Y
    Am J Clin Nutr; 2023 Jul; 118(1):41-49. PubMed ID: 37146762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum urate and heart failure: a bidirectional Mendelian randomization study.
    Yang F; Hu T; Cui H
    Eur J Prev Cardiol; 2022 Aug; 29(11):1570-1578. PubMed ID: 35578763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study.
    Wang X; Fang X; Zheng W; Zhou J; Song Z; Xu M; Min J; Wang F
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4641-e4651. PubMed ID: 34147035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic support of a causal relationship between iron status and atrial fibrillation: a Mendelian randomization study.
    Wang T; Cheng J; Wang Y
    Genes Nutr; 2022 May; 17(1):8. PubMed ID: 35637428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study.
    Habibi D; Daneshpour MS; Asgarian S; Kohansal K; Hadaegh F; Mansourian M; Akbarzadeh M
    BMC Cardiovasc Disord; 2023 Mar; 23(1):112. PubMed ID: 36882679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal effects between circulating immune cells and heart failure: evidence from a bidirectional Mendelian randomization study.
    Bian R; Xu X; Li Z
    BMC Med Genomics; 2024 Feb; 17(1):62. PubMed ID: 38408984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study.
    Tang B; Yuan S; Xiong Y; He Q; Larsson SC
    Diabetologia; 2020 Jul; 63(7):1305-1311. PubMed ID: 32270255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically determined serum bilirubin level and the risk of heart failure: A mendelian randomization study.
    Guan B; Yang M; Shen X; Wang Y; Liu Y; Liu R; Li S; Cao J
    Front Genet; 2023; 14():1067146. PubMed ID: 36713081
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study.
    Li X; Peng S; Guan B; Chen S; Zhou G; Wei Y; Gong C; Xu J; Lu X; Zhang X; Liu S
    Front Cardiovasc Med; 2021; 8():734400. PubMed ID: 34881299
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of maternal circulating 25(OH)D and calcium with birth weight: A mendelian randomisation analysis.
    Thompson WD; Tyrrell J; Borges MC; Beaumont RN; Knight BA; Wood AR; Ring SM; Hattersley AT; Freathy RM; Lawlor DA
    PLoS Med; 2019 Jun; 16(6):e1002828. PubMed ID: 31211782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.
    Wilman HR; Parisinos CA; Atabaki-Pasdar N; Kelly M; Thomas EL; Neubauer S; ; Mahajan A; Hingorani AD; Patel RS; Hemingway H; Franks PW; Bell JD; Banerjee R; Yaghootkar H
    J Hepatol; 2019 Sep; 71(3):594-602. PubMed ID: 31226389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
    Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
    Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.